CÁNCER DE MAMA
Universitat Pompeu Fabra
Barcelona, EspañaPublications en collaboration avec des chercheurs de Universitat Pompeu Fabra (6)
2023
-
Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Quality of Life Research, Vol. 32, Núm. 4, pp. 989-1003
2022
-
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Frontiers in Oncology, Vol. 11
2015
-
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
Oncotarget, Vol. 6, Núm. 42, pp. 44254-44273
-
Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design
Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315
2014
-
VAV3 mediates resistance to breast cancer endocrine therapy
Breast Cancer Research, Vol. 16, Núm. 3
2010
-
Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
Oncogene, Vol. 29, Núm. 45, pp. 6071-6083